Clincosm LogoSign in Get a demo

colorectal cancer

Showing NaN - NaN of 143
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Colorectal Cancer, MSS, Stage IV Colon Cancer Trial in Belgium, Switzerland, United States (ATP128, BI 754091, VSV-GP128)

Recruiting
  • Colorectal Cancer
  • +5 more
  • Scottsdale, Arizona
  • +10 more
Aug 15, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Informed Choice - Compass

Recruiting
  • Colorectal Cancer
  • Brief Video
  • Brief Video Plus
  • Los Angeles, California
  • +5 more
Jul 29, 2022

Subjects Treated With Autologous T Cells Using Sleeping Beauty

Not yet recruiting
  • Gynecologic Cancer
  • +9 more
  • Neoantigen specific TCR-T cell drug product
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Grand Rapids, Michigan
  • +2 more
Jul 18, 2022

Colorectal Cancer Trial in Japan, Spain, United States (M9140)

Recruiting
  • Colorectal Cancer
  • Houston, Texas
  • +4 more
Jul 15, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer Trial in Atlanta, Houston, San Antonio

Recruiting
  • Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Jun 13, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Nivolumab
  • +3 more
  • Birmingham, Alabama
  • +101 more
Jun 13, 2022

Colorectal Cancer Trial in Houston (TAS-102)

Recruiting
  • Colorectal Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Jun 7, 2022

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +5 more
  • Boston, Massachusetts
  • +4 more
May 25, 2022

Malignant Tumors of Digestive Organs, Colorectal Cancer, Colon Cancer Trial in Houston (Durvalumab, Trametinib)

Completed
  • Malignant Neoplasms of Digestive Organs
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 23, 2022

Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma Trial in United States (CBX-12)

Recruiting
  • Solid Tumor, Adult
  • +11 more
  • New Haven, Connecticut
  • +3 more
May 9, 2022

Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer Trial in Australia, Canada, United States (IDE196, Binimetinib,

Recruiting
  • Metastatic Uveal Melanoma
  • +3 more
  • Scottsdale, Arizona
  • +13 more
May 10, 2022

Colorectal Cancer Trial in Worldwide (Napabucasin, Fluorouracil, Leucovorin)

Completed
Has Results
  • Colorectal Cancer
  • Birmingham, Alabama
  • +210 more
Mar 30, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,

Recruiting
  • Metastatic Solid Tumor
  • +6 more
  • Surufatinib and Tislelizumab _ Part 1
  • Surufatinib and Tislelizumab _ Part 2
  • Tucson, Arizona
  • +17 more
Apr 1, 2022

Head and Neck Squamous Cell Carcinoma, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma Trial in United States (NKTR-255,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Mar 31, 2022

Colorectal Cancer Trial in Houston (Exercise Program, Telephone-based intervention, Counseling intervention)

Active, not recruiting
  • Colorectal Cancer
  • Exercise Program
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 29, 2022